A drug with the SMILES CCc1nnc(NC(=O)CSc2nnc(CNc3ccc(Cl)cc3)o2)s1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 2.714\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCc1nnc(NC(=O)CSc2nnc(CNc3ccc(Cl)cc3)o2)s1
CCc1nnc(NC(=O)CSc2nnc(CNc3ccc(Cl)cc3)o2)s1
[C][C][C][=N][N][=C][Branch2][Ring1][=C][N][C][=Branch1][C][=O][C][S][C][=N][N][=C][Branch1][=C][C][N][C][=C][C][=C][Branch1][C][Cl][C][=C][Ring1][#Branch1][O][Ring1][=C][S][Ring2][Ring1][Branch2]
2-[[5-[(4-chloroanilino)methyl]-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(5-ethyl-1,3,4-thiadiazol-2-yl)acetamide